2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide has been researched along with Achondroplasia, Severe, With Developmental Delay And Acanthosis Nigricans in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, A; Dinser, R; Paulsson, M; Schmitz, A; Schmitz, M; Weirich, C; Zaucke, F | 1 |
1 other study(ies) available for 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide and Achondroplasia, Severe, With Developmental Delay And Acanthosis Nigricans
| Article | Year |
|---|---|
Disruption of extracellular matrix structure may cause pseudoachondroplasia phenotypes in the absence of impaired cartilage oligomeric matrix protein secretion.
Topics: Achondroplasia; Adenoviridae; Animals; Cartilage, Articular; Cattle; Cell Survival; Cells, Cultured; Chondrocytes; Endoplasmic Reticulum; Extracellular Matrix; Extracellular Matrix Proteins; Immunohistochemistry; Indicators and Reagents; Mutation; Phenotype; Plasmids; Tetrazolium Salts; Time Factors; Transduction, Genetic; Transfection | 2006 |